Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.17
2.61%
After-hours: Aug 15, 2025, 07:37 PM EDT

Oragenics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a -37.65K -30.19K -17.02K n/a 169.17K 247.75K 264.98K 263.04K 218.51K 132.46K 102.07K 86.99K n/a n/a n/a
Cost of Revenue
2.79M 3.7M 4.02M 13.49M 12.62M 11.72M 11.07M 40.46K 48.43K 47.5K 44.67K 38.01K 34.91K 36.98K 41.24K 47.67K 50.9K 51.3K
Gross Profit
349.61K -557.17K -879.04K -13.49M -12.61M -11.7M -11.04M 122.99K 193.61K 211.76K 218.38K 180.49K 97.55K 65.09K 45.75K -22.14M -22.13M -22.12M
Operating Income
-9.53M -10.12M -10.56M -20M -19.66M -20.46M -20.9M -8.47M -10.33M -10.82M -12.53M -14.47M -14.91M -15.14M -15.77M -18.02M -18.13M -26.65M
Interest Income
47.25K 36.87K 45.9K 73.73K 114.88K 167.43K 210.39K 238.76K 229.78K 186.19K 135.9K 82.71K 58.84K 67.72K 75.85K 74.04K 72.57K 64.81K
Pretax Income
-10.3M -10.33M -10.57M -19.97M -19.52M -20.26M -20.66M -10.15M -12.05M -13.03M -14.78M -14.83M -15.3M -15.08M -15.71M -17.83M -17.94M -26.46M
Net Income
-10.3M -10.33M -10.57M -19.97M -19.52M -20.26M -20.66M -8.21M -10.08M -11.06M -14.23M -16.22M -16.73M -16.51M -15.71M -17.83M -17.94M -26.46M
Selling & General & Admin
6.2M 6.33M 6.44M 6.51M 6.28M 6M 5.45M 4.58M 4.46M 4.39M 4.47M 4.67M 4.3M 4.63M 5.27M 5.39M 5.55M 4.99M
Research & Development
3.34M 3.79M 4.11M 3.22M 3.11M 4.21M 5.22M 3.93M 5.93M 6.96M 10.03M 11.86M 12.63M 12.06M 10.59M 12.63M 12.58M 21.66M
Other Expenses
-583 -362 -234 291.00 -7.13K -20.52K -37.13K -41.32K -33.86K -50.59K -34.06K -31.59K -31.59K -1.09K 70.00 668.00 70.00 -1.13K
Operating Expenses
9.53M 10.12M 10.56M 9.73M 9.38M 10.19M 10.63M 8.6M 10.46M 11.4M 13.11M 15M 15.44M 15.23M 15.86M -4.09M -3.97M 4.54M
Interest Expense
792.38K 221.87K 29.83K 31.09K 35.29K 34.33K 30.59K 24.17K 15.23K 15.2K 15.1K 14.39K 16.22K 16.43K 15.76K 14.86K 11.69K 11.54K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.53M 10.12M 10.56M 9.73M 9.38M 10.19M 10.63M 8.6M 10.46M 11.4M 13.1M 15M 15.44M 15.23M 15.86M 18.02M 18.14M 26.65M
Income Tax Expense
n/a n/a -6.85K -10.97K -10.97K -9.51K -2.66K -56.29K -92.21K -92.49K -111.62K -62.41K -37.2K -61K -59.4K -50.87K -51.96K -44.35K
Shares Outstanding (Basic)
7.32K 1.82K 6.62M 6.53M 4.53M 3.5M 2.59M 2.36M 2.02M 2.02M 2.21M 1.95M 1.94M 1.94M 1.91M 1.94M 1.93M 1.72M
Shares Outstanding (Diluted)
7.32K 1.82K 6.62M 6.53M 4.53M 3.5M 2.59M 2.36M 2.02M 2.02M 2.21M 1.95M 1.94M 1.94M 1.91M 1.94M 1.93M 1.72M
EPS (Basic)
-1.22K -1.22K -2.1 -6.51 -6.98 -7.98 -8.69 -3.89 -5.03 -5.6 -7.29 -8.37 -8.64 -8.54 -8.48 -10.6 -12.86 -25.05
EPS (Diluted)
-1.22K -1.22K -2.1 -6.51 -6.98 -7.98 -8.69 -3.89 -5.03 -5.6 -7.29 -8.37 -8.64 -8.54 -8.48 -10.6 -12.86 -25.05
EBITDA
-9.52M -10.11M -10.53M -19.93M -19.47M -20.21M -20.6M -8.3M -10.16M -10.7M -12.45M -14.29M -14.81M -15.03M -15.66M -17.77M -17.88M -26.4M
EBIT
-9.51M -10.11M -10.54M -19.93M -19.48M -20.23M -20.62M -8.19M -10.05M -10.61M -12.35M -14.34M -14.86M -15.07M -15.7M -17.81M -17.93M -26.45M
Depreciation & Amortization
2.03M 2.04M 22.46K 20.54K 18.48K 22.94K 27.39K 40.46K 48.43K 47.5K 44.67K 38.01K 34.91K 36.98K 41.24K 47.67K 50.9K 51.3K